Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

1 Feb 2017 07:00

RNS Number : 6491V
Barr(A.G.) PLC
01 February 2017
Β 

Β 

Β 

IMMEDIATE RELEASE 1 FEBRUARY 2017

Β 

Β 

A.G. BARR p.l.c.

("A.G. BARR")

Trading Update

Β 

.

A.G. BARR p.l.c., which produces and markets some of the UK's leading brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the financial year ended 28 January 2017.

The UK soft drinks market has remained highly competitive, with the latest IRI data for the 48 weeks to 1 January 2017 showing value up c.1% and volume up c.1.5%.

Β 

Our second half trading performance strengthened, supported by successful product innovation, specifically through the launch of IRN-BRU XTRA and Rubicon Spring. Revenue for the 52 weeks ended 28 January 2017 is expected to be around Β£257m. On a like for like basis revenue growth from ongoing business* is anticipated to be c.1.5%.Β 

Β 

We have maintained tight control of our costs and, in the final quarter, successfully implemented a company-wide re-organisation that has both enhanced our organisational capability and reduced our overhead base. The operating margin for the financial year remains in line with our expectations.

Β 

Our balance sheet is robust, supported by strong free cash flow. We continue to develop the business for the long term and are pleased to announce plans to invest Β£10m in PET capability at our Milton Keynes facility, building on our already well-invested asset base to further improve efficiency and flexibility.

Β 

We believe that the combination of strong trading execution, successful innovation and tight cost control will enable us to meet our profit expectation for the year ended 28 January 2017.

Β 

Outlook

Β 

Looking ahead the uncertain economic environment indicates that 2017 will be another challenging year for UK based businesses. However our strong and flexible business model, our differentiated brands and our well-invested asset base ensure we are well placed to continue to deliver long-term value to shareholders.

Β 

A.G. BARR intends to announce its full year financial results on 28 March 2017.

Β 

For further information, please contact:

Β 

A.G. BARR Tel: 01236 852400

Roger White, Chief Executive

Stuart Lorimer, Finance Director

Β 

Instinctif Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

Β 

* Note: Like for like revenue growth from ongoing business adjusts for the effect of the 53rd week of trading and discontinued Orangina business in the prior year

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTWGUMAGUPMGQG
Date   Source Headline
11th Jul 202210:32 amRNSDirector/PDMR Shareholding
16th Jun 202210:14 amRNSDirector/PDMR Shareholding
16th Jun 202210:04 amRNSDirector/PDMR Shareholding
15th Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:42 pmRNSDirector/PDMR Shareholding
13th Jun 20221:40 pmRNSDirector/PDMR Shareholding
8th Jun 20229:53 amRNSDirectorship
27th May 20221:55 pmRNSResult of AGM
23rd May 20229:55 amRNSDirector/PDMR Shareholding
11th May 20228:53 amRNSDirector/PDMR Shareholding
26th Apr 20229:08 amRNSAnnual Financial Report / Notice of AGM
11th Apr 20221:11 pmRNSDirector/PDMR Shareholding
11th Apr 20228:51 amRNSDirector/PDMR Shareholding
11th Apr 20228:45 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSDirectorate Change
29th Mar 20222:34 pmRNSDirector/PDMR Shareholding
29th Mar 20229:37 amRNSCorrection: Final results year ended 30 Jan 2022
29th Mar 20227:00 amRNSFinal results for the year ended 30 January 2022
18th Mar 20229:02 amRNSHolding(s) in Company
8th Mar 20222:14 pmRNSDirector/PDMR Shareholding
9th Feb 20227:56 amRNSDirector/PDMR Shareholding
4th Feb 20228:32 amRNSHolding(s) in Company
4th Feb 20228:27 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTrading Update
26th Jan 202210:35 amRNSNotice of Trading Update
11th Jan 202211:28 amRNSDirector/PDMR Shareholding
8th Dec 202112:59 pmRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSInvestment in MOMA Foods Limited
29th Nov 20217:00 amRNSTrading Update
8th Nov 20212:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20211:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20219:37 amRNSDirector/PDMR Shareholding
1st Nov 202112:50 pmRNSDirector/PDMR Shareholding
11th Oct 20212:15 pmRNSDirector/PDMR Shareholding
11th Oct 20218:12 amRNSDirector/PDMR Shareholding
1st Oct 20218:49 amRNSDirector/PDMR Shareholding
1st Oct 20218:33 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim results
8th Sep 202111:39 amRNSDirector/PDMR Shareholding
31st Aug 202110:37 amRNSNotice of Interim Results Date
9th Aug 202111:21 amRNSDirector/PDMR Shareholding
3rd Aug 20217:00 amRNSH1 trading update to 1 August 2021
20th Jul 20217:00 amRNSTrading Update
19th Jul 20212:22 pmRNSHolding(s) in Company
9th Jul 20217:55 amRNSDirector/PDMR Shareholding
6th Jul 20213:32 pmRNSDirector/PDMR Shareholding - AMENDMENT
6th Jul 202112:11 pmRNSDirector/PDMR Shareholding
25th Jun 20217:00 amRNSDirectorate Changes
10th Jun 20219:01 amRNSHolding(s) in Company
8th Jun 20213:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.